Bank of America Merrill Lynch makes a couple valuation calls in healthcare this morning, upping...
Bank of America Merrill Lynch makes a couple valuation calls in healthcare this morning, upping Merck (MRK +1.2%) to Buy on optimism over its osteoporosis drug, and moving to Neutral on Bristol-Myers (BMY -0.9%) due to its limited total-return potential.
From other sites
at Zacks.com (Thu, 8:55AM)
at 4-traders.com (Tue, 5:37PM)
at 4-traders.com (Mar 24, 2015)
at Nasdaq.com (Mar 23, 2015)
at Zacks.com (Mar 17, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs